Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Novo Nordisk A/S Class B (NOVOb)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
641.9 -2.8    -0.43%
09:44:40 - Real-time Data. Currency in DKK ( Disclaimer )
  • Volume: 511,972
  • Bid/Ask: 0.0 / 0.0
  • Day's Range: 630.0 - 642.0
Type:  Equity
Market:  Denmark
ISIN:  DK0060534915 
S/N:  1772564000
Novo Nordisk B 641.9 -2.8 -0.43%
Period Ending: 2021
30/09
2021
30/06
2021
31/03
2020
31/12
Total Current Assets 91213 77146 61389 65809
Cash and Short Term Investments 35390 27216 7666 12757
Cash 29493 24229 5683 12757
Cash & Equivalents - - - -
Short Term Investments 5897 2987 1983 -
Total Receivables, Net 35452 30223 33917 32184
Accounts Receivables - Trade, Net 29860 26098 28029 27734
Total Inventory 18899 18822 18653 18536
Prepaid Expenses - - - -
Other Current Assets, Total 1472 885 1153 2332
Total Assets 174084 158095 141387 144922
Property/Plant/Equipment, Total - Net 52863 52076 51429 50269
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net - - - -
Intangibles, Net 20526 20272 20357 20657
Long Term Investments 1778 1839 1749 1648
Note Receivable - Long Term 332 413 551 674
Other Long Term Assets, Total 7372 6349 5912 5865
Other Assets, Total - - - -
Total Current Liabilities 88328 72798 72384 70273
Accounts Payable 8877 7616 6800 5717
Payable/Accrued - - - -
Accrued Expenses - - - -
Notes Payable/Short Term Debt - - - 6684
Current Port. of LT Debt/Capital Leases 1350 1301 6823 775
Other Current liabilities, Total 78101 63881 58761 57097
Total Liabilities 107972 92536 82891 81597
Total Long Term Debt 12398 12463 2832 2897
Long Term Debt 12398 12463 2832 -
Capital Lease Obligations - - - 2897
Deferred Income Tax 1643 1818 1963 2502
Minority Interest - - - -
Other Liabilities, Total 5603 5457 5712 5925
Total Equity 66112 65559 58496 63325
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 462 462 470 470
Additional Paid-In Capital - - - -
Retained Earnings (Accumulated Deficit) 65654 65100 58035 63589
Treasury Stock - Common -4 -3 -9 -8
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total - - - -726
Total Liabilities & Shareholders' Equity 174084 158095 141387 144922
Total Common Shares Outstanding 2272.06 2272.06 2272.06 2312.5
Total Preferred Shares Outstanding - - - -
* In Millions of DKK (except for per share items)
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NOVOb Comments

Write your thoughts about Novo Nordisk A/S Class B
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email